Physician

Dennis Allen Sanders, M.D.

According to 2025 Medicare claims, Dennis Sanders, M.D. (NPI: 1982603221) practices medical oncology in the Burlington-South Burlington, VT market, with the plurality of this provider's patient population coming from Franklin, VT. This provider's primary affiliated billing organization is CHAMPLAIN VALLEY HEMATOLOGY ONCOLOGY, PC (NPI: 1003248238; TIN: 462942984) and primary practice location at 05446-3052.

Sanders' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 524 traditional Medicare patients, billed 111,917 HCPCS/CPT codes, and received $3,225,116 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,218 prescription claims across 219 beneficiaries totaling $3,518,972 in drug costs, led by Imbruvica (Ibrutinib). DME data shows 14 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $824,637 to $3,518,972. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	618	113,469	$2,176,357
2016	638	135,105	$2,465,128
2017	665	136,323	$2,641,446
2018	611	121,557	$3,120,146
2019	654	155,683	$3,641,384
2020	624	168,779	$4,283,006
2021	625	173,934	$4,232,989
2022	571	138,063	$3,630,787
2023	532	108,426	$3,063,978
2024	524	111,917	$3,225,116

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	187	923	$824,637
2016	168	832	$1,109,513
2017	167	838	$1,438,001
2018	164	814	$1,544,051
2019	172	844	$1,955,093
2020	185	787	$1,793,338
2021	180	777	$2,066,968
2022	188	967	$2,695,963
2023	208	1,148	$2,635,470
2024	219	1,218	$3,518,972

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	31	$10,966
2016	N/R	40	$1,076
2017	N/R	13	$3,643
2018	N/R	30	$4,638
2019	N/R	12	$435
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	59	$1,802
2023	N/R	12	$2,552
2024	N/R	14	$455

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	165	369	$129
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	415	1,229	$88
80053	Blood test, comprehensive group of blood chemicals	278	730	$10
36415	Insertion of needle into vein for collection of blood sample	341	1,027	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	334	984	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Imbruvica	Ibrutinib	42	1,478	$602,215
Xtandi	Enzalutamide	35	1,230	$594,892
Tagrisso	Osimertinib Mesylate	32	934	$422,699
Calquence	Acalabrutinib Maleate	21	630	$315,284
Verzenio	Abemaciclib	19	532	$247,995

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	14	$455

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Dennis Allen Sanders, M.D.?

Tedicare shows public-source Medicare data for Dennis Allen Sanders, M.D. (NPI 1982603221), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Dennis Allen Sanders, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Dennis Allen Sanders, M.D.?

Dennis Allen Sanders, M.D. is linked to CHAMPLAIN VALLEY HEMATOLOGY ONCOLOGY, PC (billing NPI 1003248238) in the available physician profile data.

Does Dennis Allen Sanders, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.